General ENT News

ENT

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Burton MJ et al. – This installment features a Cochrane Review entitled “Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer,” which concludes that erythropoietin should not be administered as an addition to radiation therapy outside the experimental setting.

Related Articles

Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk
International Journal of Epidemiology, 10/08/09    Relevance Score: 84%

Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer
Otolaryngology Head and Neck Surgery, 10/13/09    Relevance Score: 83%

Clinical Features and Short-Term Outcome of Critically Ill Patients With Head and Neck Cancer in the Medical Intensive Care Unit
American Journal of Clinical Oncology, 10/07/09    Relevance Score: 83%

Sheddase Activity of Tumor Necrosis Factor-alpha Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer
Cancer Epidemiology, Biomarkers & Prevention, 10/27/09    Relevance Score: 82%

Significance and prognostic impact of co-morbidity in head and neck cancer
Journal of Cancer Research and Therapeutics, 10/27/09    Relevance Score: 82%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address